Boston, MA, United States of America

Michael Eric Green

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 8 EPO patents, primarily in Heteroaromatic Compounds. Top assignees: Pfizer Corporation, Other. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Eric Green. Retrieved from https://idiyas.com/inventor/michael-eric-green

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 95.8

 

 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Atlanta, GA (US) (2000)
  • Mystic, CT (US) (2014)
  • Silverthorne, CO (US) (2018)
  • Boston, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2000-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heteroaromatic Compounds
Dopamine D1 Ligands
Neurodegenerative Disorders
Spliceostatin Analogs
Substituted Pyrido[1,2-a]Pyrazines
Bicyclic Pyridinones
Kappa Opioid Ligands
Pre-rolled Smoking Paper
24 patents (USPTO):Explore Patents

Certainly! Here's the draft for the article on inventor Michael Eric Green:

Title: Unveiling the Innovations of Michael Eric Green in Pharmacotherapy

Introduction:

In the bustling city of Boston, MA, resides a remarkable inventor by the name of Michael Eric Green. With a prolific track record and a keen focus on pharmacotherapy, Green has made significant contributions to the medical field through his groundbreaking inventions and patents.

Latest Patents:

Among his impressive portfolio of 21 patents, one of his latest inventions revolves around "Heteroaromatic compounds and their use as dopamine D1 ligands." These compounds hold great promise in treating a spectrum of disorders, ranging from schizophrenia and cognitive impairment to Parkinson's disease and chronic apathy.

Career Highlights:

Michael Eric Green is a key figure at Pfizer Corporation, a renowned pharmaceutical company at the forefront of innovation in healthcare. His tenure at Pfizer has been marked by a dedication to developing novel solutions for complex medical conditions, showcasing his expertise in pharmacology and drug development.

Collaborations:

Green's innovative work is further amplified through collaborations with esteemed colleagues such as Michael Aaron Brodney and David Lawrence Firman Gray. Together, they form a dynamic team driving advancements in pharmacotherapy and enhancing the quality of patient care.

Conclusion:

In conclusion, Michael Eric Green stands as a beacon of ingenuity in the realm of pharmacotherapy, with a stellar record of patents reflecting his commitment to improving healthcare outcomes. His contributions continue to shape the landscape of medicine, offering hope and healing to countless individuals worldwide.

If you need any further modifications or additional details, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…